Cannabigerol (CBG) is like an ancestor which nurtures the 3 major cannabinoid branches: cannabidiolic acid (CBDA), tetrahydrocannabinolic acid (THCA), and cannabichromenic acid (CBCA). CBGA (Cannabigerolic Acid) constitutes the first cannabinoid produced in the plant. Thereon, CBGA gets modified into CBDA, THCA or CBCA through the action of enzymes. The capacity to generate cannabigerolic acid (CBGA) makes the cannabis plant so unique.
The cannabis plant contains natural enzymes, known as synthases, that break down the CBGA and target it toward the preferred branch. CBG comprises a non-psychoactive cannabinoid that is presently undergoing research for a host of medical properties. While it has been less studied than the more popular cannabinoids such as CBD or THC, the research conducted so far indicates that it has an extensive range of medical advantages.
Cannabigerol (CBG) comprises a secure and natural medicine, which greatly benefits people who are suffering from gastritis and it’s symptoms. CBG also triggers the growth of brain cell (neurogenesis), combats tumors, and functions as an antibacterial.
Gastritis – What It Is
Gastritis manifests itself through inflammation within the gut and can take many forms. The inflammation at the core of this condition popularly results from a bacterial strain called Helicobacter pylori, which is amongst the most prevalent bacterial infections. Nevertheless, only a chosen number of people who get infected by the bacteria experience gastritis symptoms. This is the outcome of many factors, like lifestyle, genetics, and environmental factors.
In the matter of lifestyle options, gastritis can occur following use of spicy foods, alcohol, radiation therapy, autoimmune issues, anti-inflammatory medications, and Crohn’s disease. These factors can cause inflammation of the gut lining, resulting in inflammation of the mucosa. The protective layer can ultimately be damaged by the condition, causing stomach acid to damage the stomach lining.
Gastritis can cause a host of discomforting symptoms, which can progress to stomach ulcers and also a greater chance of stomach cancer. One main symptom of the ailment includes a burning pain, that targets the stomach area and within the upper abdomen. Various symptoms comprise nausea, bloating, vomiting, belching, indigestion, bloating, and absence of appetite.
CBG can work to lessen a few symptoms resulting from the condition, and may really act at a deeper level to suppress the inflammation at its root. The cannabinoid attaches to CB1 receptors inside the gut, leading to tissue repair.
How CBG Helps In Gastritis
CBG comprises an effective alpha-2-adrenoceptor agonist and mildly potent 5-HT1A-receptor antagonist. This furnishes CBG with an extensive range of therapeutic applications as an antidepressant, for dermatological uses, and like an analgesic.
An Italian study indicates that CBG’s powerful anti-inflammatory features can help people with inflammatory bowel disease and gastritis. This study showed CBG to standardize a variety of inflammatory markers within the human body, decrease oxidative harm-causing free radicals within the human body and increase levels of a body’s individual antioxidant – superoxide dismutase. Free radicals can harm any portion of the body’s tissues, from DNA to connective tissue proteins, resulting in greater inflammation, and inflammation is the body’s reaction to damage.
CBG targets particular molecules leading to inflammation in various disease states like cancer and pain syndromes. Actually, studies show CBG may operate as a COX-2 inhibitor – similar to the extensively used non-steroidal anti-inflammatory drugs (NSAIDs).
How Cannabinoids Affect Our GI System
Modulating the action of the endocannabinoid system affects different gastrointestinal physiological and pathophysiological procedure. Moreover, cannabinoid receptors plus regulatory enzymes causing synthesis or decay of endocannabinoids represent likely targets to lessen the progress of gastrointestinal mucosal lesions, inflammation, and hemorrhage. Direct triggering of CB1 receptors by cannabinoids like CBG effectively lessens gastric acid as well as gastric motor activity. Further, it also reduces the development of gastric mucosal lesions sparked by stress, NSAIDs or alcohol, and pylorus ligation.
Moreover, stimulation of both CB receptors was displayed to relieve intestinal inflammation in different models of rats, to reduce visceral hypersensitivity and abdominal pain. Besides, these receptors also lessened colitis-linked hypermotility and diarrhea. Furthermore, CB1 receptors subdue secretory procedures and also regulate intestinal epithelial barrier activities.
Cannabinoids were found to restrict secretion of gastric acid and exert an immunomodulatory, mostly immunosuppressive impact. CBG also helps patients of gastritis manage its symptoms like nausea, inflammation, loss of appetite and mood disorders.
Researchers are delighted with these initial CBG outcomes and are sponsoring future research with CBG only or CBG in association with different cannabinoids and treatments for the cure of various maladies. As it is non-psychotropic, CBG has an impressively wide spectrum of probable applications not just for gastritis, but even as an analgesic, antidepressant and as a treatment for psoriasis.